Skip to content

Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer

Prospective Study of Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion and Endoscopic Tumor Size Estimation for Early Gastric Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01832246
Enrollment
560
Registered
2013-04-16
Start date
2014-12-31
Completion date
2015-12-31
Last updated
2014-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early Gastric Cancer, Gastric Tumor

Keywords

endoscopy, endosonography, stomach cancer, tumor staging

Brief summary

The accurate prediction of depth of tumor invasion in early gastric cancer is essential for the proper selection of candidates for endoscopic resection. Conventional endoscopy and endoscopic ultrasonography have been useful diagnostic method for depth of invasion in early gastric cancer. However, there has been no prospective comparative study on the accuracy between the 2 methods. Therefore, the investigators prospectively compare the accuracy between the 2 methods regarding prediction of depth of invasion.

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with early gastric adenocarcinoma undergo both endoscopic staging and endoscopic ultrasonographic staging for depth of invasion

Exclusion criteria

* patients had previously received neoadjuvant chemotherapy or chemoradiotherapy * patients with obviously advanced gastric cancer by endoscopy * the evidence of distant metastasis or extensive adjacent organ invasion on abdominal CT scan

Design outcomes

Primary

MeasureTime frame
diagnostic accuracy between endoscopic ultrasonographic staging and conventional endoscopic stagingup to 2.5 years (end of study, December 2014)

Countries

South Korea

Contacts

Primary ContactJeongmin Choi, M.D.
doct00@hanmail.net82-2-2072-7209

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026